Komori
Bando Chemical Industries (5195) · InitiativeRestated

Sustaining Innovation and Disruptive Innovation

First written in FY2016. 18 of 34 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026-H1.

34entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorse2016: 320162017: 420172018: 420182019: 320192020: 420202021: 420212022: 420222023: 420232024: 220242025: 22025
Same theme, other companies
Creating new products and businesses through sustaining and disruptive innovationA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「The amount invested in research and development activities for the Group as a whole during the interim consolidated accounting period, including improvement and development activities, was ¥2,164 million. Of this amount, ¥532 million was for research and development of new products. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」

    The Group recognized ¥2,164 million in research and development activities and ¥532 million in research and development expenses for new products. It stated that there were no material changes in the status of its research and development activities.
  2. FY2025AdvancedAnnual report

    「Research and development is conducted mainly through the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, which had 246 employees at the end of the consolidated fiscal year. The Group invested ¥4,259 million in development and research during the consolidated fiscal year, including improvement and development activities overall. No development costs were recognized as intangible assets.」

    The research and development structure comprised 4 locations and 246 employees, with ¥4,259 million invested in development and research.
  3. FY2025-H1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,074 million during the interim consolidated fiscal period. Of this amount, ¥496 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the interim consolidated fiscal period.」

    The company recorded ¥2,074 million in R&D activities and ¥496 million in new products, while stating that there were no significant changes in the status of its R&D activities.
  4. FY2024-Q3AdvancedAnnual report

    「The company began selling Pull-Out Alert®, a healthcare device that detects removal motions and uses its proprietary C-STRETCH® stretchable strain sensor.」

    The company describes the launch of sales of a new healthcare device using C-STRETCH® as a specific achievement of sustaining and disruptive innovation.
  5. FY2024-Q2RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,014 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥522 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company recorded ¥2,014 million in R&D activities and ¥522 million in R&D expenditure for new products, while stating that there were no significant changes in the status of its R&D activities.
  6. FY2024-Q1AdvancedAnnual report

    「As a new addition to the Sunline® Belt light-duty conveyor-belt lineup, the company began selling Mister Porters™, a logistics-conveyance belt with excellent low-noise performance.」

    The company describes progress from product development to market launch through the launch of sales of a new low-noise product.
  7. FY2023AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, with 243 employees at the end of the current consolidated fiscal year. The company invested ¥4,110 million in development and research during the consolidated fiscal year, including overall improvement and development; there were no development costs recognized as intangible assets.」

    With an R&D structure centered on 4 sites and 243 employees, the company invested ¥4,110 million in development and research in fiscal 2022. It also describes multiple new product launches and product commercialization.
  8. FY2023-Q3AdvancedAnnual report

    「The company completed development of the Willtia™ Sheet, a water-repellent and permeable sheet for concrete formwork that uses the company’s proprietary water-repellent technology to conserve resources, and began test sales in November 2022. It also developed the Ceptor®-Ⅹ S3M/S5M toothed belt, part of the Ceptor® series lineup, with improved power transmission capacity and modulus of elasticity compared with existing products, providing high power transmission, high-load capability and high responsiveness. The group’s R&D activities, including improvement and development, amounted to ¥3,100 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥767 million was R&D expenditure for new products.」

    In addition to the development and test sales of new products, the company reports ¥3,100 million in R&D activities and ¥767 million in R&D expenditure for new products.
  9. FY2023-Q2RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,073 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥519 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company recorded ¥2,073 million in R&D activities and ¥519 million in new products, while stating that there were no significant changes in the status of its R&D activities.
  10. FY2023-Q1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥1,050 million during the first quarter of the current cumulative consolidated period. Of this amount, ¥262 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the first quarter of the current cumulative consolidated period.」

    The company recorded ¥1,050 million in R&D activities and ¥262 million in new products, while stating that there were no significant changes in the status of its R&D activities.
  11. FY2022AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, with 242 employees at the end of the current consolidated fiscal year. The company invested ¥4,029 million in development and research during the consolidated fiscal year, including overall improvement and development; there were no development costs recognized as intangible assets.」

    The R&D structure comprises 4 sites and 242 employees, and the company invested ¥4,029 million in development and research. The company also describes multiple new product launches and development achievements.
  12. FY2022-Q3RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥3,003 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥739 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the third quarter of the current cumulative consolidated period.」

    The company recorded ¥3,003 million in R&D activities and ¥739 million in new products, while stating that there were no significant changes in the status of its R&D activities.
  13. FY2022-Q2AdvancedAnnual report

    「The company began selling the Ceptor®-Ⅹ Plus (Ceptor Ten Plus), a new high-load toothed belt with a longer service life, higher power transmission capacity and greater compactness than the existing Ceptor®-Ⅹ, as part of the Ceptor® series lineup. It also began selling the UVH-specification toothed belt for banknote/card conveyance, featuring improved oil resistance, as part of its lineup of toothed belts for precision conveyance. The group’s R&D activities, including improvement and development, amounted to ¥1,990 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥480 million was R&D expenditure for new products.」

    In addition to the launch of sales of 2 new products, the company reports ¥1,990 million in R&D activities during the first half and ¥480 million in R&D expenditure for new products.
  14. FY2022-Q1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥991 million during the first quarter of the current cumulative consolidated period. Of this amount, ¥247 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the first quarter of the current cumulative consolidated period.」

    The company recorded ¥991 million in R&D activities and ¥247 million in new products, reconfirming that there were no significant changes in the status of its R&D activities.
  15. FY2021AdvancedAnnual report

    「R&D activities are conducted mainly at the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, with 232 employees at the end of the current consolidated fiscal year. The company invested ¥4,094 million in development and research during the consolidated fiscal year, including overall improvement and development and ¥7 million in development costs recognized as intangible assets.」

    The R&D structure comprises 4 sites and 232 employees, and the company invested ¥4,094 million in development and research. It is also advancing development of low-cost manufacturing technology for CNF-compounded chloroprene rubber.
  16. FY2021-Q3AdvancedAnnual report

    「In the medical equipment field, which the company has pursued as one of the pillars of its new businesses, its consolidated subsidiary Aimedic MMT Co., Ltd. developed and began selling the AT Measure, which applies the technology of the C-STRETCH® elastic strain sensor developed independently by the company. The group’s R&D activities, including improvement and development, amounted to ¥2,990 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥820 million was R&D expenditure for new products.」

    The company describes the launch of sales of the AT Measure, applying C-STRETCH®, as a specific achievement of a new product. It invested ¥2,990 million in R&D activities and ¥820 million in new products.
  17. FY2021-Q2AdvancedAnnual report

    「The company began selling the Mister Silky Touch™ non-stick food belt, offering excellent release and slip properties on the belt surface, and the Tekuria® EGS-T thin polyethylene film for building materials, which reduces CO2 emissions and waste over its lifecycle from production through disposal. The group’s R&D activities, including improvement and development, amounted to ¥2,006 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥562 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company describes the launch of sales of 2 new products, while investing ¥2,006 million in R&D activities and ¥562 million in new products and stating that there were no significant changes in the status of its activities.
  18. FY2021-Q1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥1,010 million during the first quarter of the current cumulative consolidated period. Of this amount, ¥272 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the first quarter of the current cumulative consolidated period.」

    The company invested ¥1,010 million in R&D activities and ¥272 million in new products, while stating that there were no significant changes in the status of its R&D activities.
  19. FY2020AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, with 220 employees at the end of the current consolidated fiscal year. The company invested ¥4,421 million in development and research during the consolidated fiscal year, including overall improvement and development and ¥103 million in development costs recognized as intangible assets.」

    The R&D structure comprises 4 sites and 220 employees, and the company invested ¥4,421 million in development and research.
  20. FY2020-Q3RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥3,268 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥931 million was for R&D for new products. There were no significant changes in the status of the group’s R&D activities during the third quarter of the current cumulative consolidated period.」

    The company recorded ¥3,268 million in R&D activities and ¥931 million in R&D for new products during the first 3 quarters, while stating that there were no significant changes in its R&D activities.
  21. FY2020-Q2RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,196 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥631 million was for R&D for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company recorded ¥2,196 million in R&D activities and ¥631 million in R&D for new products, reconfirming that there were no significant changes in the status of its R&D activities.
  22. FY2019AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the New Business Promotion Center, Monozukuri Center, Fundamental Technology Research Institute and Power Transmission Technology Research Institute, with 227 employees at the end of the current consolidated fiscal year. The company invested ¥4,459 million in development and research during the consolidated fiscal year, including overall improvement and development and ¥120 million in development costs recognized as intangible assets.」

    The R&D structure comprises 4 sites and 227 employees, and the company invested ¥4,459 million in development and research.
  23. FY2019-Q3RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥3,315 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥1,060 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the third quarter of the current cumulative consolidated period.」

    The company recorded ¥3,315 million in R&D activities and ¥1,060 million for new products during the first 3 quarters, while stating that there were no significant changes in the status of its R&D activities.
  24. FY2019-Q2RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,161 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥696 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company recorded ¥2,161 million in R&D activities and ¥696 million for new products during the first half, while stating that there were no significant changes in the status of its R&D activities.
  25. FY2019-Q1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥1,083 million during the first quarter of the current cumulative consolidated period. Of this amount, ¥353 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the first quarter of the current cumulative consolidated period.」

    The company recorded ¥1,083 million in R&D activities and ¥353 million for new products, while stating that there were no significant changes in the status of its R&D activities.
  26. FY2018AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the R&D Center, Monozukuri Center and Production Technology Development Center, with 139 employees at the end of the current consolidated fiscal year, and the Power Transmission Technology Research Institute, with 68 employees. The company invested ¥4,375 million in development and research during the consolidated fiscal year, including overall improvement and development.」

    The company reports staffing at its R&D sites and invested ¥4,375 million in development and research, including improvement and development.
  27. FY2018-Q3AdvancedAnnual report

    「The company also developed the BANDO DEC-20™ foreign-material inspection tool, which enables the visualization of falling particles, an issue in cleanrooms and other facilities. The group’s R&D activities, including improvement and development, amounted to ¥3,284 million during the third quarter of the current cumulative consolidated period. Of this amount, ¥863 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the third quarter of the current cumulative consolidated period.」

    While stating that there were no significant changes in the status of its R&D activities, the company describes the development of BANDO DEC-20™ as a new product achievement. R&D activities amounted to ¥3,284 million, including ¥863 million for new products.
  28. FY2018-Q2RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥2,159 million during the second quarter of the current cumulative consolidated period. Of this amount, ¥564 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the second quarter of the current cumulative consolidated period.」

    The company recorded ¥2,159 million in R&D activities and ¥564 million in R&D expenditure for new products during the first half, while stating that there were no significant changes in the status of its activities.
  29. FY2018-Q1RestatedAnnual report

    「The group’s R&D activities, including improvement and development, amounted to ¥1,082 million during the first quarter of the current cumulative consolidated period. Of this amount, ¥285 million was R&D expenditure for new products. There were no significant changes in the status of the group’s R&D activities during the first quarter of the current cumulative consolidated period.」

    The company disclosed ¥1,082 million in quarterly R&D activities and ¥285 million in R&D expenditure for new products, while stating that there were no significant changes in the status of its R&D activities.
  30. FY2017AdvancedAnnual report

    「Based on these guidelines, R&D activities are conducted mainly at the R&D Center, Monozukuri Center, Production Technology Development Center, with 138 employees at the end of the current consolidated fiscal year, and the Power Transmission Technology Research Institute, with 66 employees. The company invested ¥4,298 million in development and research during the consolidated fiscal year, including overall improvement and development.」

    Under the framework of sustaining and disruptive innovation, the company invested ¥4,298 million in R&D and describes achievements including FR7700, BANDO FR-BIOS™, Free Crystal® and C-STRETCH®.
  31. FY2017-Q3AdvancedAnnual report

    「We also developed “Power Ace® Aramid Combo,” a bonded narrow V-belt incorporating Japan's first high-elasticity aramid cord, in response to demand for larger, higher-load and more compact industrial machinery.」

    The company describes the development of a new product using high-elasticity aramid core wire as a specific achievement of sustaining innovation.
  32. FY2017-Q2AdvancedAnnual report

    「We also advanced the improvement and development of existing products and developed the FR7000 series of flame-retardant, heat-resistant conveyor belts with self-extinguishing properties, which can be used for high-temperature conveying applications and was the first such product developed in Japan.」

    The company describes progress in developing the specific FR7000 series as part of its improvement and development of current products.
  33. FY2017-Q1AdvancedAnnual report

    「In addition to improving and developing existing products, we developed products in new business areas, including the optical clear adhesive sheet “Free Crystal®.”」

    The company describes progress in improving and developing current products and developing products for new businesses, including specific product names.
  34. FY2016First statedAnnual report

    「Under Guideline 2, “Product Evolution,” the company aims to accelerate the development of “market-optimized” products that match market needs in each region worldwide, continuously creating and developing products that contribute to customers’ “reduced environmental impact, higher efficiency, compactness and functional integration” (Incremental Innovation: Sustaining Innovation). Under Guideline 4, “Creation of New Businesses,” the company aims to refine its core technologies for the formulation, dispersion and compounding of elastomers and resins for priority markets, develop new products and cultivate new markets based on “distinctive technologies” created by combining and refining these technologies with new technologies, and develop them into pillars of future new businesses (Radical Innovation: Disruptive Innovation).」

    The company classifies improvements to existing products and the creation of new businesses through new technologies as different types of innovation. R&D expenditure for the fiscal year was ¥4,244 million.
Moved together

"Development of Market-Optimized Specifications and High-Value-Added Products" moved the same way as this thread, in the same document, in 18 of its 34 moves.

181514997★123456
  1. ★This thread
  2. 1Development of Market-Optimized Specifications and High-Value-Added Products18×
  3. 2Creating New Businesses and Developing New Markets15×
  4. 3Evolution of the Global Market Strategy14×
  5. 4Globally Optimized Production Structure and Global Cost Competitiveness9×
  6. 5Improving Profitability through Cost Reduction9×
  7. 6Flexible capital policy through share buybacks7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Bando Chemical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Sustaining Innovation and Disruptive Innovation | Bando Chemical Industries,Ltd. (5195) | Komori